Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles

被引：45
|
作者：
Dupuy, C [1 ]
BuzoniGatel, D [1 ]
Touze, A [1 ]
LeCann, P [1 ]
Bout, D [1 ]
Coursaget, P [1 ]
机构：
[1] FAC PHARM TOURS, LAB IMMUNOL MALAD INFECT, F-37200 TOURS, FRANCE
来源：
MICROBIAL PATHOGENESIS | 1997年 / 22卷 / 04期
关键词：
HPV; cervical cancer; virus-like particles; cell mediated immunity; cytokines; Th1; profile;
D O I：
10.1006/mpat.1996.0113
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Recombinant human papillomavirus (HPV) type 16 L1 virus-like particles (VLPs) expressed in the baculovirus system were used to investigate the cellular immune response to human papillomavirus type 16. The cell-mediated immune response was evaluated through immunization of mice with HPV 16 L1 virus-like particles using a lymphoproliferation assay and cytokine production and cytometric analysis of lymphocyte subsets. A significant proliferative response was observed which was associated with secretion of both interferon-gamma and interleukin-2. FAGS analysis of splenic lymphocytes revealed that CD8(+) T-cells were increased in the immunized mice. These results demonstrate that HPV 16 L1 VLPs induce a T-cell response characterized by a Th1 profile and confirm that the HPV 16 VLP is a reasonable candidate for vaccine development. (C) 1997 Academic Press Limited.
引用
收藏
页码：219 / 225
页数：7
相关论文
共 50 条
  • [41] Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells
    Hyoung Jin Kim
    Seo Young Cho
    Min-Hye Park
    Hong-Jin Kim
    Archives of Pharmacal Research, 2018, 41 : 544 - 553
  • [42] Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells
    Kim, Hyoung Jin
    Cho, Seo Young
    Park, Min-Hye
    Kim, Hong-Jin
    ARCHIVES OF PHARMACAL RESEARCH, 2018, 41 (05) : 544 - 553
  • [43] The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system
    Touze, A
    El Mehdaoui, S
    Sizaret, PY
    Mougin, C
    Muñoz, N
    Coursaget, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) : 2046 - 2051
  • [44] Human Papillomavirus (HPV) L1 and L1-L2 Virus-Like Particle-Based Multiplex Assays for Measurement of HPV Virion Antibodies
    Hernandez, Brenda Y.
    Ton, Thien
    Shvetsov, Yurii B.
    Goodman, Marc T.
    Zhu, Xuemei
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (09) : 1348 - 1352
  • [45] Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine
    Luxembourg, Alain
    Brown, Darron
    Bouchard, Celine
    Giuliano, Anna R.
    Iversen, Ole-Erik
    Joura, Elmar A.
    Penny, Mary E.
    Restrepo, Jaime A.
    Romaguera, Josefina
    Maansson, Roger
    Moeller, Erin
    Ritter, Michael
    Chen, Joshua
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) : 1313 - 1322
  • [46] Long-term immunogenicity of a human papillomavirus 16 L1 virus-like particle vaccine
    Ault, KA
    Wheeler, C
    Brown, D
    Koutsky, L
    Wiley, DJ
    Jansen, K
    Barr, E
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (04): : 25S - 26S
  • [47] HPV16 L1 diversity and its potential impact on the vaccination-induced immunity
    El Aliani, Aissam
    El Abid, Hassan
    Kassal, Yassmine
    Khyatti, Meriem
    Attaleb, Mohammed
    Ennaji, Moulay Mustapha
    El Mzibri, Mohamed
    GENE, 2020, 747
  • [48] Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
    Brown, DR
    Fife, KH
    Wheeler, CM
    Koutsky, LA
    Lupinacci, LM
    Railkar, R
    Suhr, G
    Barr, E
    Dicello, A
    Li, WL
    Smith, JF
    Tadesse, A
    Jansen, KU
    VACCINE, 2004, 22 (21-22) : 2936 - 2942
  • [49] Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and-18 cervical cancer vaccine
    Deschuyteneer, Michel
    Elouahabi, Abdelatif
    Plainchamp, Dominique
    Plisnier, Michel
    Soete, Dominique
    Corazza, Yvon
    Lockman, Laurence
    Giannini, Sandra
    Deschamps, Marguerite
    HUMAN VACCINES, 2010, 6 (05): : 407 - 419
  • [50] Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection
    Haupt, Richard M.
    Wheeler, Cosette M.
    Brown, Darron R.
    Garland, Suzanne M.
    Ferris, Daron G.
    Paavonen, Jorma A.
    Lehtinen, Matti O.
    Steben, Marc
    Joura, Elmar A.
    Giacoletti, Katherine E. D.
    Radley, David R.
    James, Margaret K.
    Saah, Alfred J.
    Sings, Heather L.
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (11) : 2632 - 2642
12345